TTM
$4.02
YoY change
+7.4%
5Y CAGR
+22.9%
Peak year (2025)
$3.92
Latest annual
$3.92
EPS (Diluted) history chart for Xylem (XYL) from 2009 to 2025
Latest: $3.92
EPS (Diluted) growth chart for Xylem (XYL) from 2009 to 2025
Latest: +7.4%
EPS (Diluted) history table for Xylem (XYL) from 2009 to 2025
| 2025 | $3.92 | +7.4% | +$0.27 | ||
| 2024 | $3.65 | +30.8% | +$0.86 | ||
| 2023 | $2.79 | +42.3% | +$0.83 | ||
| 2022 | $1.96 | -16.6% | −$0.39 | ||
| 2021 | $2.35 | +67.9% | +$0.95 | ||
| 2020 | $1.40 | -36.7% | −$0.81 | ||
| 2019 | $2.21 | -27.1% | −$0.82 | ||
| 2018 | $3.03 | +65.6% | +$1.20 | ||
| 2017 | $1.83 | +26.2% | +$0.38 | ||
| 2016 | $1.45 | -22.5% | −$0.42 | ||
| 2015 | $1.87 | +2.2% | +$0.04 | ||
| 2014 | $1.83 | +50.0% | +$0.61 | ||
| 2013 | $1.22 | -23.3% | −$0.37 | ||
| 2012 | $1.59 | +6.0% | +$0.09 | ||
| 2011 | $1.50 | -15.7% | −$0.28 | ||
| 2010 | $1.78 | +25.4% | +$0.36 | ||
| 2009 | $1.42 | — | — |
- 2025$3.92+7.4%
- 2024$3.65+30.8%
- 2023$2.79+42.3%
- 2022$1.96-16.6%
- 2021$2.35+67.9%
- 2020$1.40-36.7%
- 2019$2.21-27.1%
- 2018$3.03+65.6%
- 2017$1.83+26.2%
- 2016$1.45-22.5%
- 2015$1.87+2.2%
- 2014$1.83+50.0%
- 2013$1.22-23.3%
- 2012$1.59+6.0%
- 2011$1.50-15.7%
- 2010$1.78+25.4%
- 2009$1.42—
EPS (Diluted) values are taken from Xylem's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Xylem (XYL)
According to Xylem's latest reported financial statements, the company's current diluted EPS (TTM) is $4.02. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Xylem (XYL) reported diluted EPS of $3.92 – grew 7.4% year-over-year.
Xylem diluted EPS compound annual growth for the 2020–2025 (5 years) window is +22.9%, sustaining 3 straight years of year-over-year growth.
Across the available history, diluted EPS reached its high of $3.92 in 2025 and its low of $1.22 in 2013.
Xylem EPS (Diluted) by Year
Xylem EPS (Diluted) 2025: $3.92
Xylem posted diluted EPS of $3.92 in 2025, grew 7.4% from 2024. This figure represents the highest annual value in the available history.
Xylem EPS (Diluted) 2024: $3.65
In 2024, Xylem reported diluted EPS of $3.65, surged 30.8% from 2023.
Xylem EPS (Diluted) 2023: $2.79
Xylem diluted EPS in 2023 was $2.79, surged 42.3% from 2022.
Xylem EPS (Diluted) 2022: $1.96
2022's diluted EPS for Xylem came in at $1.96, declined 16.6% below 2021.
Xylem EPS (Diluted) 2021: $2.35
Xylem diluted EPS in 2021 was $2.35.
See more financial history for Xylem (XYL). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Industrials peers of Xylem (XYL), ranked by their latest diluted EPS
| $18.83 | |
| $18.50 | |
| $11.97 | |
| $10.46 | |
| $8.16 | |
| $4.96 | |
| $2.48 | |
| −$1.69 |
- $18.83
- $18.50
- $11.97
- $10.46
- $8.16
- $4.96
- $2.48
- −$1.69
Frequently asked questions
Xylem (XYL) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation